Company: AIP
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001667011-25-000022
Chunk: 0

Company: Arteris, Inc.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
Item 1. Financial Statements

Arteris, Inc.

Condensed Consolidated Balance Sheets

(In thousands, except share and per share data)

(Unaudited)

As ofMarch 31,2025December 31, 2024ASSETSCurrent assets:Cash and cash equivalents$16,371 $13,684 Short-term investments (Note 5)25,942 30,157 Accounts receivable, net of allowance of $115 and $131 as of March 31, 2025 and December 31, 2024, respectively10,268 20,608 Prepaid expenses and other current assets4,823 4,634 Total current assets57,404 69,083 Property and equipment, net3,434 4,019 Long-term investments (Note 5)12,779 8,504 Equity method investment4,987 5,802 Operating lease right-of-use assets4,327 3,838 Intangibles, net2,803 3,024 Goodwill4,178 4,178 Other assets8,407 7,687 TOTAL ASSETS$98,319 $106,135 LIABILITIES AND STOCKHOLDERS’ DEFICITCurrent liabilities:Accounts payable$227 $539 Accrued expenses and other current liabilities13,710 15,899 Operating lease liabilities, current1,047 917 Deferred revenue, current40,172 40,445 Vendor financing arrangements, current1,383 1,482 Total current liabilities56,539 59,282 Deferred revenue, noncurrent33,552 35,177 Operating lease liabilities, noncurrent3,495 2,998 Vendor financing arrangements, noncurrent368 594 Deferred income, noncurrent7,340 7,631 Other liabilities1,846 1,641 Total liabilities103,140 107,323 Commitments and contingencies (Note 10)Stockholders' deficit:Preferred stock, par value of $0.001 - 10,000,000 shares authorized as of both March 31, 2025 and December 31, 2024; no shares issued and outstanding as of both March 31, 2025 and December 31, 2024— — Common stock, par value of $0.001 - 300,000,000 shares authorized as of both March